Home
Pharmsynthez

Pharmsynthez Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainpharmsynthez.com

Year Founded--

Employees51 - 200

Annual Revenue$10M - $15M

Pharmsynthez

Pharmsynthez (including company regionals)

pharmsynthez.com

See more website traffic and engagement information

Pharmsynthez Revenue up to June 2026 is 10M - 15M

revenue generated by Pharmsynthez top domains

Pharmsynthez top domains revenue over 3 years

Revenue for Pharmsynthez top domains

pharmsynthez.com10M - 15M

See more with Sales Intelligence

Total visits to Pharmsynthez's top domains

Understand Pharmsynthez market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

pharmsynthez.com2.3K

See more with Sales Intelligence

Avg. visit duration in Pharmsynthez's top domains

Analyze Pharmsynthez engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

pharmsynthez.com00:00:55

See more with Sales Intelligence

Avg. pageviews on Pharmsynthez's top domains

See how Pharmsynthez keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

pharmsynthez.com1.98

See more with Sales Intelligence

Pharmsynthez top competitors by domain

Top similar sites in June 2026, ranked by their affinity

pharm-sintez.ruCompany NameAO Pharm-SintezEmployees51 - 200HQRussia, MoscowAnnual revenue$5M - $10MTotal visits2.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Pharmsynthez

These are the website technologies, by industry, used by Pharmsynthez top domains

Widget (8)

Twemoji

Payment & Currencies (6)

Visa

Conversion & Analytics (3)

Google Analytics

Advertising (2)

PubMatic

More Technologies

4

See all

News & Signals from Pharmsynthez

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHiFiBiO Therapeutics, Inc. partnered with Pharmsynthez on Nov 23rd '20.HiFiBiO Therapeutics, a multinational biotherapeutics company with unique expertise in immune modulation and single cell science, today announced a partnership with Russian pharmaceutical company, Pharmsynthez PJSC (MOEX: LIFE), and Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry RAS (IBCh).

NewsPharmsynthez is developing preventative vaccine against COVID-19.Pharmsynthez is working on the development of a preventative vaccine against COVID-19 based on pseudoviral nanoparticles.

NewsXeneticbio partners with Pharmsynthez.Thinly traded nano cap Xenetic Biosciences ( XBIO +7.6% ) enters into a master services agreement with St. Petersburg, Russia-based PJSC Pharmsynthez aimed at advancing development of its XCART technology for B-cell cancers.